HCV | WEBCASTS

Beginning Date

11/30/2015

Ending Date

11/30/2016

1.0

credit

1.0

contact hour

Speakers

Nancy Reau, MD
Associate Director of Solid Organ Transplantation,
Section Chief, Hepatology Rush University Medical Center
Chicago, IL

Tram Tran, MD
Medical Director, Liver Transplantation
Cedars-Sinai Medical Center
Los Angeles, CA

Webcast

All webcast must be viewed in their entirety to claim credit.

Accredited by:

This program is endorsed by the International Coalition of Hepatology Educational Providers and provided by the Chronic Liver Disease Foundation.

This program Supported by:

AbbVie, Bristol-Myers Squibb, Gilead,
Intercept Pharmaceuticals, and Merck.

Target Audience

This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, internists, primary care providers, nurse practitioners/physician assistants, allied health care professionals, clinical pharmacists, and managed care decision makers.

Educational Objectives

At the conclusion of this activity, participants will be able to:

•	Identify the risk factors and overall disease processes in chronic liver diseases
•	Describe current and evolving treatment strategies for chronic liver diseases in order to optimize patient outcomes
•	Effectively adhere to long-term surveillance recommendations outlined in the AASLD guidelines

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-Hep). The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #0797-9999-15-044-H04-P. This program is designated for up to 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.0 contact hour may be earned for successful completion of this activity.

Disclosure of Conflicts of Interest:

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower the Chronic Liver Disease Foundation (CLDF), and the International Coalition of Hepatology Education Providers (IC-HEP) have no relationships to disclose.

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees' professional development.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosures:

Dr. Nancy Reau has disclosed that she has received Grants/Research Support from Bristol-Myers Squibb, Gilead, and AbbVie. Also, Dr. Reau serves on the Advisory Boards for Merck, Bristol-Myers Squibb, AbbVie, Salix, and Janssen. It has been disclosed that she has Editorial Board Involvement with Medscape as well.

Dr. Tram Tran has disclosed that she has received Grants/Research Support and Honorarium from Gilead, Bristol-Myers Squibb, AbbVie, Merck, and Janssen. In addition, Dr. Tran serves as a Consultant/Speaker Bureau Member and on the Advisory Boards for Gilead, Bristol-Myers Squibb, AbbVie, Merck and Janssen.

HCV | WEBCASTS

1.0

1.0

Speakers

Webcast

Accredited by:

This program Supported by:

Subscribe